Zymeworks Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
ZYME$31.46+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Loss and Comprehensive Income (
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)
(Expressed in thousands of U.S. dollars except share and per share data)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenue | ||||
| Research and development collaborations (note 9) | $48,726 | $19,243 | $75,836 | $29,273 |
| Operating expenses: | ||||
| Research and development | 34,449 | 29,163 | 70,187 | 61,205 |
| General and administrative | 14,951 | 15,679 | 31,936 | 31,469 |
| Impairment on acquired IPR&D (note 6) | — | 17,287 | — | 17,287 |
| Total operating expenses | 49,400 | 62,129 | 102,123 | 109,961 |
| Loss from operations | (674) | (42,886) | (26,287) | (80,688) |
| Other income: | ||||
| Interest income | 3,426 | 5,154 | 6,850 | 11,074 |
| Other income, net (note 10) | (621) | 114 | (572) | 418 |
| Total other income, net | 2,805 | 5,268 | 6,278 | 11,492 |
| Income (loss) before income taxes | 2,131 | (37,618) | (20,009) | (69,196) |
| Income tax recovery (expense) | 186 | (68) | (310) | (143) |
| Net income (loss) | 2,317 | (37,686) | $(20,319) | $(69,339) |
| Other comprehensive income (loss): | ||||
| Unrealized income (loss) on available for sale securities, net of tax of nil (note 5) | 66 | (180) | 612 | (1,301) |
| Total other comprehensive income (loss) | 66 | (180) | 612 | (1,301) |
| Comprehensive income (loss) | $2,383 | $(37,866) | (19,707) | (70,640) |
| Net earnings (loss) per common share (note 4): | ||||
| Basic | $0.03 | $(0.49) | (0.27) | (0.91) |
| Diluted | $0.03 | $(0.49) | (0.27) | (0.91) |
| Weighted-average common stock outstanding (note 4): | ||||
| Basic | 75,337,168 | 76,392,593 | 75,254,553 | 76,303,713 |
| Diluted | 77,378,449 | 76,396,217 | 75,302,357 | 76,321,941 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.